SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced seven new commercial coverage decisions for Prolaris ...
Sight Sciences stock surged on Medicare coverage for TearCare—opening a big dry eye market. Learn more about the company.
A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...
In recent years, the integration of artificial intelligence (AI) into various sectors has been nothing short of revolutionary. One such sector experiencing transformative change is health insurance, ...
In a groundbreaking decision issued May 21, 2025, the Michigan Court of Appeals handed down a pivotal win for car crash victims across the state, particularly those injured by a negligent family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback